In a similar approach, exosomes from HEK293 cells engineered to produce an EGFR-specific peptide ligand, and transfected with let-7a mimic, delivered let-7a mimic to EGFR-expressing breast cancer xenografts and inhibited their growth (99). The gene discussed is EGFR; the disease is breast carcinoma.